Literature DB >> 15923365

Activation of PAR4 induces a distinct actin fiber formation via p38 MAPK in human lung endothelial cells.

Masakazu Fujiwara1, Enjing Jin, Mohammad Ghazizadeh, Oichi Kawanami.   

Abstract

Protease-activated receptors (PARs) are multifunctional G protein-coupled receptors. Among the four existing PARs, PAR4 is preferentially expressed in the human lung tissue. However, the function of PAR4 has not been defined in the lung endothelial cells. Because PAR1-mediated cellular effects are deeply related to the morphological changes, we focused on the actin fiber and p38 mitogen-activated protein kinase (MAPK) signaling involved in actin polymerization to elucidate the role of PAR4. RT-PCR and Western blot analyses identified PAR4 expression in human pulmonary artery endothelial cells and in human microvascular endothelial cells from lung. We then examined the changes in actin fibers in endothelial cells treated with PAR4-activating peptide. PAR1-activating peptide was used for comparison. Activation of PAR4 and PAR1 by their corresponding peptides induced actin fiber formation; however, the actin filaments were broadly bundled in PAR4 as compared with the ringlike actin filaments in PAR1 activation. Correspondingly, the magnitude of p38 MAPK phosphorylation was different between cells treated with PAR4 and PAR1, with PAR4-activating peptide showing a significantly higher sensitivity to p38 MAPK inhibitor, SB203580. Taken together, these results demonstrate that activation of PAR4 results in the formation of actin fiber distinct from that by PAR1 activation, suggesting PAR4 may play specific roles in the lung endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923365     DOI: 10.1369/jhc.4A6592.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Authors:  Kohei Tatsumi; Clare M Schmedes; E Reaves Houston; Emily Butler; Nigel Mackman; Silvio Antoniak
Journal:  Cell Immunol       Date:  2019-07-03       Impact factor: 4.868

3.  Modulation of PAR(1) signalling by benzimidazole compounds.

Authors:  S Asteriti; S Daniele; F Porchia; M T Dell'Anno; A Fazzini; I Pugliesi; M L Trincavelli; S Taliani; C Martini; M R Mazzoni; A Gilchrist
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

Review 5.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

6.  Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells.

Authors:  Ming Wang; Shuhong An; Diyi Wang; Haizhen Ji; Xingjing Guo; Zhaojin Wang
Journal:  J Immunol Res       Date:  2018-09-30       Impact factor: 4.818

Review 7.  Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

Authors:  Márta L Debreczeni; Zsuzsanna Németh; Erika Kajdácsi; Henriette Farkas; László Cervenak
Journal:  Clin Rev Allergy Immunol       Date:  2021-03-16       Impact factor: 8.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.